前收盘价格 | 36.32 |
收盘价格 | 36.42 |
成交量 | 302,153 |
平均成交量 (3个月) | 95,450 |
市值 | 7,437,575,680 |
市盈率 (P/E TTM) | 28.22 |
预期市盈率 (P/E Forward) | 27.47 |
价格/销量 (P/S) | 0.560 |
股市价格/股市净资产 (P/B) | 2.86 |
52周波幅 | |
利润日期 | 27 Aug 2025 |
股息率 (DY TTM) | 2.64% |
营业毛利率 | 1.95% |
营业利益率 (TTM) | 3.58% |
稀释每股收益 (EPS TTM) | 1.30 |
季度收入增长率 (YOY) | -9.00% |
季度盈利增长率 (YOY) | -18.90% |
总债务/股东权益 (D/E MRQ) | 70.12% |
流动比率 (MRQ) | 1.22 |
营业现金流 (OCF TTM) | 432.61 M |
杠杆自由现金流 (LFCF TTM) | 338.65 M |
资产报酬率 (ROA TTM) | 4.15% |
股东权益报酬率 (ROE TTM) | 10.37% |
市场趋势
短期 | 中期 | ||
行业 | Medical Distribution (AU) | 混合的 | 混合的 |
Medical Distribution (全球的) | 看跌 | 看跌 | |
股票 | EBOS FPO NZ [EBO] | - | - |
AIStockmoo 评分
分析师共识 | 0.0 |
内部交易活动 | NA |
价格波动 | -0.5 |
技术平均移动指标 | 0.0 |
技术振荡指标 | 4.0 |
平均 | 0.88 |
Ebos is the largest pharmaceutical wholesaler and distributor across Australia and New Zealand. It services community pharmacies and hospitals, which contribute around 60% and 30% of revenue, respectively. Drug pricing and wholesale margins for PBS medicine are governed by the Australian government’s Pharmaceutical Benefits Scheme, or PBS. Wholesale gross margins are capped at 7% for community pharmacy and 10% for hospitals, and ongoing price reform typically results in low-single-digit revenue growth. Aside from pharma distribution, Ebos operates an animal health product wholesale, manufacturing and retail business, as well as undertaking third party logistics services. These segments are smaller contributors to group revenue but due to the unregulated nature are higher-margin operations. |
|
部门 | Healthcare |
行业 | Medical Distribution |
投资方式 | Mid Core |
内部持股比例 | 8.83% |
机构持股比例 | 25.12% |
该时间范围内无数据。
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能(AI)模型生成的,请谨慎解读。
投资组合